Latest Breaking News On - Samsara biocapital - Page 4 : comparemela.com

For an AI startup, a high valuation is good news. Right?

We’re untangling an emerging phenomenon: that a high valuation can sometimes be a detriment, rather than an asset, when it comes to recruiting key AI talent.

Enlaza Therapeutics Raises $100M in Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

DekaBank Deutsche Girozentrale Sells 9,191 Shares of Zymeworks Inc. (NYSE:ZYME)

DekaBank Deutsche Girozentrale decreased its position in Zymeworks Inc. (NYSE:ZYME – Free Report) by 70.5% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 3,843 shares of the company’s stock after selling 9,191 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Zymeworks were worth $40,000 as […]

Form DEFA14A Eliem Therapeutics, Inc.

Leap Therapeutics (LPTX) Prices 12.66M Share Private Placement at $2.82/sh